Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.1%

12 terminated/withdrawn out of 170 trials

Success Rate

89.2%

+2.7% vs industry average

Late-Stage Pipeline

36%

61 trials in Phase 3/4

Results Transparency

11%

11 of 99 completed trials have results

Key Signals

11 recruiting11 with results6 terminated6 withdrawn

Enrollment Performance

Analytics

N/A

57(39.6%)

Phase 3

39(27.1%)

Phase 4

22(15.3%)

Phase 2

17(11.8%)

Phase 1

8(5.6%)

Early Phase 1

1(0.7%)

144Total

N/A(57)

Phase 3(39)

Phase 4(22)

Phase 2(17)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (170)

Showing 20 of 170 trials

NCT02446444Phase 3Active Not Recruiting

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

Role: collaborator

NCT06262776Not ApplicableRecruiting

Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients

Role: collaborator

NCT06992141Early Phase 1Completed

A Strep Throat Controlled Human Infection Trial in Healthy Adults

Role: collaborator

NCT05402657Not ApplicableCompleted

The RAFT ECT Study

Role: collaborator

NCT03057106Phase 2Active Not Recruiting

Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC

Role: collaborator

NCT07434180Phase 2Not Yet Recruiting

Phase II Trial of Lu-177 FAP-2286 in Patients With Carcinoma of Unknown Primary

Role: collaborator

NCT04478370Not ApplicableCompleted

Characterizing Humoral Immune Response to Mosquito Bites

Role: collaborator

NCT00430989Phase 4Completed

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

Role: collaborator

NCT01320345Phase 3Active Not Recruiting

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

Role: collaborator

NCT01424150Not ApplicableCompleted

REstrictive Versus LIbEral Fluid Therapy in Major Abdominal Surgery: RELIEF Study

Role: collaborator

NCT02632760Phase 4Completed

Intravenous Iron for Treatment of Anaemia Before Cardiac Surgery

Role: collaborator

NCT04192435Phase 4Completed

Tranexamic Acid to Reduce Infection After Gastrointestinal Surgery

Role: collaborator

NCT05742243Phase 2Completed

Insulin and Abatacept in Recently-diagnosed Type 1 Diabetes

Role: collaborator

NCT07136584Not ApplicableRecruiting

SOS for Caregiver Wellbeing

Role: collaborator

NCT07224347Active Not Recruiting

Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)

Role: collaborator

NCT03136445Phase 3Completed

TRial to EvaluAte Tranexamic Acid Therapy in Thrombocytopenia

Role: collaborator

NCT06522854Phase 3Withdrawn

Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings

Role: collaborator

NCT05180942Recruiting

Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS

Role: collaborator

NCT02273375Phase 3Active Not Recruiting

Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC

Role: collaborator

NCT05394363Recruiting

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Role: collaborator